Immunodeficiency
📧 Sign up to get email alerts when something new happens for Immunodeficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France [NA]
A completed clinical trial update assessing the prevalence of bronchiectasis in patients with primary humoral immunodeficiency, including CV…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT [Phase 2]
Phase 2 study evaluating reduced-intensity conditioning for non-malignant disorders undergoing umbilical cord blood transplantation (UCBT), …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
This clinical trial aims to characterize autoreactive B lymphocytes in autoimmune diseases and immune deficiencies. The study status is not …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Quality of Life Among Children With Inborn Error of Immunity
This clinical trial from Sohag University will assess quality of life in children with primary immunodeficiency, but the study is not yet re…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Severe Immune Cytopenia Registry Www.Sic-reg.Org
This entry provides a completed update on the Severe Immune Cytopenia Registry (SIC-reg), sponsored by the Medical University of Graz, cover…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Clozapine-related Immunodeficiency in Parkinsons Disease [Phase 4]
A phase 4 clinical trial is investigating clozapine-related immunodeficiency in Parkinson's disease and is currently recruiting. The study i…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
This is a completed NIAID clinical trial update describing sample collection for evaluating immune systems in patients with unknown or incom…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency [Phase 2]
A Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation using briquilimab-based conditioning in participants …
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial evaluating multiple natural products and compounds (Omega-3, Nigella sativa, Indian costus, quinine, anise se…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Assessing Patient Preference for Infusion Systems [NA]
This clinical trial update describes a study to assess patient preference for infusion systems in individuals with primary and secondary imm…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Primary Immunodeficiencies and Obstetrical Neuraxial Anaesthesia
This completed clinical trial evaluated safety issues related to obstetrical neuraxial anesthesia in patients with primary immunodeficiencie…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Immune Cells in Diabetic Chronic Foot Ulcers
Karolinska Institutet is conducting a clinical trial to study the role of immune cells in healing diabetic chronic foot ulcers; the study is…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies
Completed clinical trial examining upper airway manifestations in primary ciliary dyskinesia and primary immunodeficiencies.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection [Phase 2]
A Phase 2 clinical trial evaluating Adenovirus-specific cytotoxic T-lymphocytes for refractory Adenovirus infection in patients with primary…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) [Phase 2]
Phase 2 clinical trial evaluating Virus Specific Cytotoxic T-Lymphocytes to treat refractory cytomegalovirus infections in individuals with …
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection [Phase 2]
Phase 2 trial of EBV-specific cytotoxic T-lymphocytes for refractory Epstein-Barr virus infection is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections in Children and Young Adults [Phase 1]
Phase 1 trial evaluating R-MVST Cells for treatment of viral infections in children and young adults is currently recruiting, assessing safe…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant [Phase 1, Phase 2]
Results from a Phase 1/2 trial of bilateral orthotopic lung transplantation with bone marrow transplantation in primary immunodeficiency hav…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: COVID-19 Vaccine Responses in PIDD Subjects
This clinical trial update describes COVID-19 vaccine responses in patients with primary immunodeficiency diseases (PIDD), including X-linke…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC
This clinical trial update describes an expanded access protocol using alpha/beta T and CD19+ depleted peripheral blood stem cells. It targe…
-
EMA approval · 2025-05-16EMA Authorised: Deqsiga (human normal immunoglobulin) — Takeda Manufacturing Austria AG
EMA authorised Deqsiga, a human normal immunoglobulin product from Takeda Manufacturing Austria AG, for several immunologic and neuropathic …
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Vaccine-induced Immunity in Immunocompromised Patients
A study sponsored by the University of Cologne is currently recruiting immunocompromised patients to assess vaccine-induced immunity.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Frequency of Skin Diseases in Children with Inborn Errors of Immunity
This clinical trial update notes a study investigating the frequency of skin diseases in children with inborn errors of immunity, currently …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: COVID-19 in PID Survey
A clinical trial update notes a study evaluating COVID-19 in individuals with primary immunodeficiency that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Blood Samples to Identify Biomarkers of Busulfan
A terminated clinical trial at Fred Hutchinson Cancer Center investigated using blood samples to identify biomarkers of busulfan exposure. T…